Lexeo Therapeutics, Inc. Common Stock (LXEO) vs Rocket Pharmaceuticals, Inc. (RCKT)
A side-by-side comparison of Lexeo Therapeutics, Inc. Common Stock and Rocket Pharmaceuticals, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
LXEO
Lexeo Therapeutics, Inc. Common Stock
$3.35HealthcareDelayed quote: Oct 6, 2026, 12:25 PM EDT
RCKT
Rocket Pharmaceuticals, Inc.
$2.51HealthcareDelayed quote: Oct 6, 2026, 12:25 PM EDT
Total return — LXEO vs RCKT
growth of $100 · dividends reinvested · last 3yLXEO -66.1% (-30.3%/yr)RCKT -86.4% (-48.6%/yr)LXEO compounded faster over this window
LXEO RCKT
LXEO vs RCKT: by the numbers
- •RCKT is the larger company ($274M vs $263M market cap).
Metrics side by side
Valuation
| Metric | LXEO | RCKT |
|---|---|---|
| P/B ratio | 1.12 | 0.74 |
Profitability
| Metric | LXEO | RCKT |
|---|---|---|
| Gross margin | 0.00% | 0.00% |
| Operating margin | 0.00% | 0.00% |
| Net margin | 0.00% | 0.00% |
| ROE | -37.12% | -4.68% |
| ROIC | -39.76% | -48.92% |
Growth (annualized)
| Metric | LXEO | RCKT |
|---|---|---|
| Total return CAGR (5Y) | N/A | -38.33% |
Go deeper
Dig into the metrics
Lexeo Therapeutics, Inc. Common Stock ROERocket Pharmaceuticals ROELexeo Therapeutics, Inc. Common Stock operating marginRocket Pharmaceuticals operating marginLexeo Therapeutics, Inc. Common Stock revenue growthRocket Pharmaceuticals revenue growthLexeo Therapeutics, Inc. Common Stock free cash flowRocket Pharmaceuticals free cash flow
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.